September 25, 2023
The pharmaphorum podcast
Listen to our CEO, Young Kwon discuss Alchemab's innovative platform and its novel approach to drug discovery on the pharmaphorum podcast.
Learn More
September 5, 2023
Young at the Wells Fargo 2023 Healthcare Conference
Listen to CEO Young Kwon chat with Wells Fargo analyst Derek Archila at the Wells Fargo 2023 Healthcare Conference. Live webcast scheduled for Sep 7, 2023 at 4:30 pm ET.
Learn More
August 23, 2023
The Optimum Perspectives Podcast
Our CEO Young Kwon was delighted to speak with Richard Staines of the Optimum Perspectives Podcast on how Alchemab is revolutionizing antibody drug discovery with a novel alternative to the classic "choose a target" approach.
Learn More
June 21, 2023
Alchemab unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium 2023
Alchemab's Sandrine Legg, Director of Phenotypic Screening presented data on a potential first-in-class disease-modifying therapeutic for Alzheimer's disease at the Antibody Industrial Symposium in Tours, France on 22 June 2023.
Learn More
May 5, 2023
Alchemab presents new data at CHDI Huntington’s Disease Therapeutics Conference 2023
Alchemab’s Donna Finch, Head of Translational and Clinical Science, presented data on a potential first-in-class disease modifying therapeutic for Huntington’s Disease at the annual CHDI Huntington’s Disease Therapeutics Conference in Dubrovnik, Croatia, on the 26 April 2023.
Learn More
14th November 2022
04/05/2022
Jane talks at Genomics England Research Summit
Watch our CSO Jane Osbourn give a talk at the Genomics England Research Summit presenting our incredible work to date!
Learn More
4th May 2022
PEGS Boston 2022 – Parallel Discovery of Therapeutic Antibodies and Novel Targets Using Antibody Repertoires of Resilient Individuals
Watch Jorge Dias, Alchemab Principal Scientist and early member of the team, talk at PEGS Boston on ‘Parallel Discovery of Therapeutic Antibodies and Novel Targets Using Antibody Repertoires of Resilient Individuals’
Learn More
4th May 2022
Genomics England Research Summit – Mining the immune system for protective antibodies
Learn more about B cell immune repertoires from Jane Osbourn, Alchemab CSO & co-founder, presenting at the Genomics England Research Summit
Learn More
24th March 2022
GTC 2022
Catch a replay of Alchemab’s Jin Leem presenting at Nvidia’s GTC 2022 on deciphering the language of antibodies
Learn More